Akèy › Pinéalom
Etid klinik pou Pinéalom ap rekrite nan Etazini
8 etid pou Pinéalom ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Ap rekriteFaz 1
Laj 5 a 18 · Tout sèks · Mizajou Sep 15, 2026 · NCT06357377GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Sep 11, 2026 · NCT07087002B7-H3.CD28Z.CART in CNS Neoplasms
Ap rekriteFaz 1
Laj 2 a 21 · Tout sèks · Mizajou Sep 3, 2026 · NCT07390539Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Jun 17, 2026 · NCT06193759A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
Ap rekriteFaz 1 bonè
Laj 3 a 21 · Tout sèks · Mizajou Apr 29, 2026 · NCT07017816Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Ap rekriteFaz 1
Laj 1 a 26 · Tout sèks · Mizajou Apr 13, 2026 · NCT04185038Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT04541082International PPB/DICER1 Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
0 Minutes – 100 Years · Tout sèks · Mizajou Jan 30, 2025 · NCT03382158Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.